About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

How PUMILIO1 Gene Mutation Studies in Mice Translate to Humans

by Anjali Aryamvally on February 24, 2018 at 2:02 PM
Font : A-A+

How PUMILIO1 Gene Mutation Studies in Mice Translate to Humans

Mutations in human PUMILIO1 gene also cause conditions similar to a neurological condition called spinocerebellar ataxia type 1 (SCA1), shows study published in Cell. SCA1 is a disease characterized by progressive problems with balance. SCA1 is generally caused due to a mutation that produces an abnormal, very long version of the Ataxin1 protein that forms clumps inside neurons.

However, studies on animal models have shown that accumulation of normal, regular-length Ataxin1 can lead to neurodegeneration similar to SCA1. In this case, the problem was a mutation in one of the genes that regulate Ataxin1 production, called PUMILIO1 that resulted in overproduction of normal Ataxin1. Inspired by the findings in animal models, an international team of researchers explored the possibility that a similar phenomenon happened in people.

Advertisement


These findings provide a better understanding of the genetic basis of neurological diseases and suggest that identifying protein regulators would single out new candidates for disease-causing genes.

"In this study, we investigated the possibility that our findings in mice - that mutations in Ataxin1 regulator Pumilio1 cause a neurological disease similar to SCA1 - would translate to people," said first author Dr. Vincenzo Gennarino, a postdoctoral fellow in Dr. Huda Zoghbi's lab at Baylor College of Medicine during the development of this work, and currently an assistant professor of genetics and development at Columbia University Medical Center.
Advertisement

The amount of a single protein can affect the manifestation of a disease

The researchers began by searching for patients with symptoms similar to those of SCA1 in large genomic databases around the world. They identified 15 patients with different mutations of PUMILIO1 gene, which they separated into two groups. In one group, the amount of PUMILIO1 protein was about half that detected in people without the condition. These patients presented with a severe form of the disease that had started early, between 5 months and 1 year of age. The children have seizures, ataxia, poor motor coordination and developmental delay. In the other group of patients, the amount of PUMILIO1 was 75 percent of that present in individuals without the condition. These patients presented with a milder form of ataxia that appeared in their 40s or 50s.

"This study, which is a nice example of the power of collaborations, taught us that mutations in the same gene can cause vastly different neurological problems based on how much they compromise the protein product," said corresponding author Dr. Huda Zoghbi, professor of molecular and human genetics and of pediatrics and neuroscience at Baylor and director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi also is an investigator at the Howard Hughes Medical Institute.

"We found these findings very exciting," Gennarino said. "We learned that the characteristics of the disease vary according to the levels of PUMILIO1 protein. We used to think that modest changes in the levels of certain proteins, such as a 25 percent deficiency, had no detrimental effect on the individual. Here we found that this is not the case. This is an important finding from the clinical point of view. An individual born with a 25 percent deficiency of PUMILIO1 or perhaps other proteins may only develop symptoms later in life."

These findings also have implications for other neurodegenerative conditions such as Alzheimer's disease, amyotrophic lateral sclerosis, or Lou Gehrig's disease, and Parkinson's disease. Identifying the regulators of proteins involved in these diseases would provide a list of candidate genes potentially linked to the condition and open new venues for novel therapeutic strategies.

"We hope that this study encourages other researchers to look back at their own studies from the perspective of the regulators of protein synthesis or clearance," Gennarino said.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Cystic Fibrosis McArdle Disease Weaver Syndrome Inherited Breast Cancer Syndromes Von Hippel-Lindau Disease / Rare Genetic Disorder How Do Viruses Mutate and Why Does it Matter? 

Recommended Reading
Spinocerebellar Ataxia
Spinocerebellar ataxia (SCA) is a progressive, neurodegenerative, genetic disease, which has no ......
Researchers Identify Novel Proteins Linked to Huntington's Disease
These newly identified mutant proteins kill neurons and build up in regions of the brain that are .....
Smoking Cessation Drug Improves Walking Function in Patients With Ataxia
Varenicline - a drug approved for smoking cessation improved walking ability in patients suffering ....
Treatments For Spinocerebellar Ataxia Can Be Developed Using The New Model System
A new model system that can be used to develop drug therapies for genetic disorders like ......
Cystic Fibrosis
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has ...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
How Do Viruses Mutate and Why Does it Matter?
Mutations are the sudden changes that occur in genetic materials. They occur as a part of evolution ...
Inherited Breast Cancer Syndromes
Inherited breast cancers are caused due to mutations in genes that increase the risk of breast cance...
McArdle Disease
McArdle disease is a genetic disorder in which the body cannot breakdown glycogen in the muscles. It...
Von Hippel-Lindau Disease / Rare Genetic Disorder
Von Hippel-Lindau Disease (VHL) or Von Hippel-Lindau Syndrome is a rare genetic disorder caused by a...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)